This test is most useful if any of these apply to you.
Your cortisol level on any given morning is one snapshot. What happens to that cortisol after your body produces it tells a different story, and that downstream story is where the long-term consequences live. The amount of cortisol you metabolize each day shapes whether stress signaling is quietly contributing to weight gain, insulin resistance, hormonal imbalance, or fatigue.
b-THF (b-tetrahydrocortisol, also written as 5b-tetrahydrocortisol) is one of the main inactive breakdown products of cortisol. It is measured in dried urine and gives you a read on how much cortisol your liver is clearing and which enzyme systems are doing the work. It is a research-grade marker, used most often as part of a panel rather than in isolation, and it pairs with related metabolites to reveal patterns a single blood cortisol cannot.
Cortisol leaves your bloodstream mostly through the liver, where enzymes flatten and inactivate it before the kidneys release the products in urine. b-THF is one of those end products, formed when cortisol passes through an enzyme called 5b-reductase. Its sibling, 5a-THF, comes from a parallel enzyme called 5a-reductase. The third major metabolite, tetrahydrocortisone (THE), comes from cortisol that was first converted to cortisone elsewhere in the body.
Because b-THF reflects this whole pipeline, it tracks two things at once: how much cortisol you produced and how quickly your liver cleared it. Researchers typically read it alongside 5a-THF and THE rather than as a standalone number. The combined value (5a-THF + b-THF + THE) is often called total cortisol metabolites and is treated as a rough estimate of total daily cortisol output.
Two ratios using b-THF are particularly useful. The first is (5a-THF + b-THF) divided by THE, which estimates the activity of an enzyme called 11b-HSD1 (11-beta-hydroxysteroid dehydrogenase type 1) that reactivates cortisone back into active cortisol inside tissues like fat and liver. Higher activity here means your body is generating extra local cortisol even when blood levels look normal. The second is b-THF divided by 5a-THF, which compares your 5b-reductase activity against your 5a-reductase activity, a balance that shifts in conditions like PCOS (polycystic ovary syndrome).
In a study of 40 women, those with moderate obesity excreted more 5a-THF and 5b-THF than lean controls, even though their blood cortisol was the same. The increase suggests the body is producing more cortisol in the background and clearing it faster, with extra reactivation happening inside fat tissue. A larger study of 191 children found the same pattern: obese boys and girls excreted more steroid metabolites than normal-weight peers, with the gap most pronounced before puberty.
This matters because elevated local cortisol generation in fat and liver is one of the proposed mechanisms behind central weight gain, fatty liver, and insulin resistance. In 41 morbidly obese patients, overexpression of the cortisol-reactivating enzymes in liver and visceral fat tracked with hyperinsulinemia. Your blood cortisol can look unremarkable while this hidden loop is running.
Cortisol metabolite patterns are altered in PCOS in a specific way. In 79 women, those with PCOS showed enhanced 5a-reduction of cortisol, which lowers blood cortisol and prompts the brain to push out more ACTH (adrenocorticotropic hormone), driving the adrenal glands to make more androgens. A meta-analysis covering multiple PCOS studies confirmed that elevated 5a-reductase activity is consistent across populations and tracks with insulin resistance independent of body weight. In 135 women with adrenal androgen excess in PCOS, the picture was mirrored on the other side: increased 5b-reductase activity also lowered cortisol and pushed the same ACTH-driven loop.
Because the kidneys clear these metabolites, kidney function changes the picture. In 97 patients on hemodialysis, urinary cortisol metabolites accumulated and 11b-HSD activity appeared reduced, reflecting impaired clearance rather than a healthier cortisol system. In obstructive jaundice, bile acids suppress 5b-reduction in the liver, lowering b-THF output even though cortisol production is unchanged. Both situations can mimic or mask a genuine cortisol problem.
In a trial of 174 adults with Addison's disease, switching from three-times-daily hydrocortisone to a once-daily dual-release form normalized urinary cortisol metabolites, bringing total b-THF, 5a-THF, and THE excretion closer to healthy controls. People taking standard hydrocortisone often run a touch high on metabolites, which has been associated with the metabolic side effects of replacement therapy.
b-THF is not a simple high-equals-bad or low-equals-good marker. High values can mean overproduction (obesity, PCOS), accelerated clearance (some metabolic syndromes), or reduced cortisone formation (licorice use). Low values can mean reduced production (cystic fibrosis, pediatric type 1 diabetes), impaired liver 5b-reduction (cholestatic liver disease), or accumulation upstream that has not yet reached the metabolite stage. The number itself is a window into a pattern; the value comes from interpreting it against companion measurements and your clinical context.
There are no standardized clinical cutpoints for b-THF. The best population-based reference data come from a study of 1,128 healthy adults measured by mass spectrometry, which derived age- and sex-specific reference intervals for 40 urinary steroid metabolites including b-THF. Men generally excrete more b-THF than women, and excretion shifts with age and time of day. Because labs report this metabolite in dried urine, normalized to creatinine (ng/mg), absolute numbers vary by assay. Compare your results within the same lab over time rather than against any single fixed threshold.
| Tier | What It Suggests |
|---|---|
| High b-THF with high total metabolites | Elevated cortisol production or accelerated metabolism, often seen in obesity, PCOS, or metabolic syndrome |
| Low b-THF with low total metabolites | Reduced cortisol production, impaired liver 5b-reduction, or reduced peripheral metabolism |
| High (5a-THF + b-THF)/THE ratio | Increased 11b-HSD1 activity, suggesting more cortisol reactivation in tissues like fat and liver |
| Low (5a-THF + b-THF)/THE ratio | Possible licorice intake, apparent mineralocorticoid excess, or kidney enzyme defects |
These categories are interpretive patterns, not diagnostic cutpoints. Use them as orientation only.
Cortisol metabolism has meaningful day-to-day variation. A single dried urine sample captures one window, and population studies confirm that excretion changes with time of day, sex, age, kidney function, and recent stress or illness. The number is more useful as a trend than a single reading. Get a baseline, retest in 3 to 6 months if you are actively changing diet, body weight, or training load, and at least annually thereafter if you are watching for slow metabolic drift. Pair every retest with measurements of related metabolites so you can interpret patterns rather than chase isolated numbers.
Because b-THF lives in interpretive ratios rather than fixed thresholds, an abnormal result is a prompt to investigate, not a diagnosis. If your total cortisol metabolites are high and the (5a-THF + b-THF)/THE ratio is also high, the pattern points toward elevated 11b-HSD1 activity, and pairing this with fasting insulin, HbA1c (hemoglobin A1c), and a lipid panel can show whether the metabolic loop is already affecting your blood sugar or cholesterol. If the THF/THE ratio is low and you suspect chronic licorice exposure, removing it and retesting in 4 to 6 weeks clarifies the picture. If b-THF is unexpectedly low alongside symptoms of adrenal fatigue, pair it with morning serum cortisol, ACTH, and DHEA-sulfate. An endocrinologist can help interpret the panel if results are persistent or extreme.
Evidence-backed interventions that affect your b-THF level
b-Tetrahydrocortisol is best interpreted alongside these tests.
b-Tetrahydrocortisol is included in these pre-built panels.